Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Temodal 100mg capsules
0801050Y0BBAAAA
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 140mg capsules
0801050Y0BBAEAE
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 180mg capsules
0801050Y0BBAFAF
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 20mg capsules
0801050Y0BBADAD
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 250mg capsules
0801050Y0BBABAB
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 5mg capsules
0801050Y0BBACAC
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.